A Follow-up Study to Evaluate the Long-term Persistence of GSK Biologicals' Candidate CMV Vaccine Administered to Male Adults
Latest Information Update: 26 Aug 2023
At a glance
- Drugs Cytomegalovirus glycoprotein vaccine (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 05 Jun 2017 New trial record